INO-6160

DNA vaccine encoding native-like HIV Env trimer and interleukin-12 · Inovio Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INO-6160, covering 2025-07-04 to 2025-07-04. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial to Evaluate the Safety and Immunogenicity of Synthetic DNAs Encoding a Native-like HIV Env Trimer and Interleukin-12 (INO-6160), Alone or in a Prime-boost Regimen With 3M-052-AF + Alum Adjuvanted VRC HIV Env Trimer 4571 in Adult Participants Without HIV [Phase 1]

See pricing